Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06WML
|
|||
| Former ID |
DNC005239
|
|||
| Drug Name |
5-Ethyl-3,4-diphenyl-isoxazole
|
|||
| Synonyms |
CHEMBL361504; 5-Ethyl-3,4-diphenyl-isoxazole; 3,4-diphenyl-5-ethylisoxazole; SCHEMBL2279510; MXTWADCRLRQMDW-UHFFFAOYSA-N; ZINC13583259
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H15NO
|
|||
| Canonical SMILES |
CCC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=CC=C3
|
|||
| InChI |
1S/C17H15NO/c1-2-15-16(13-9-5-3-6-10-13)17(18-19-15)14-11-7-4-8-12-14/h3-12H,2H2,1H3
|
|||
| InChIKey |
MXTWADCRLRQMDW-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib: reversal cyclooxygenase-2 selectivity by sulfonamide group removal. J Med Chem. 2004 Sep 23;47(20):4881-90. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.